1988
DOI: 10.1016/0304-3959(88)90187-x
|View full text |Cite
|
Sign up to set email alerts
|

Pain following spinal cord injury: result from a postal survey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

1997
1997
2021
2021

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 80 publications
(6 citation statements)
references
References 1 publication
0
5
0
1
Order By: Relevance
“…Pain is a major problem among patients with SCI, imposing several limitations to the patients. A previous study in England reported that 11% of patients with SCI consider pain rather than mobility disorder as a deterrent in their daily activities [ 18 ]. Another study reported 37% of patients with high level lesions and 23% of patients with low level lesions were willing to exchange loss of reacquired physiologic functions for pain relief [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Pain is a major problem among patients with SCI, imposing several limitations to the patients. A previous study in England reported that 11% of patients with SCI consider pain rather than mobility disorder as a deterrent in their daily activities [ 18 ]. Another study reported 37% of patients with high level lesions and 23% of patients with low level lesions were willing to exchange loss of reacquired physiologic functions for pain relief [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Chronic pain may complicate spinal cord injury in as many as 60% of cases [49] and is usually difficult to manage. For a thorough account of assessment and management of this problem, the reader is directed to the chapter by Glynn and Teddy [50].…”
Section: Pathophysiologymentioning
confidence: 99%
“…El baclofeno, agonista GABA, tiene el riesgo de producir hiperespasticidad de rebote con su retirada, y su uso perioperatorio no presenta interacciones anestésicas relevantes. Debe tenerse en cuenta que hasta el 60% de los pacientes con LMC presentan dolor crónico tanto neuropático como nociceptivo y su manejo es complicado 9 . La retirada de tratamiento neuropático en el perioperatorio presenta el riesgo de desencadenar un empeoramiento del dolor, si bien el mantenimiento de fármacos como la amitriptilina supone un riesgo proarritmogénico, y el mantenimiento de la duloxetina tiene el riesgo de producir un síndrome serotoninérgico.…”
Section: A H E a D O F P R I N T Discusiónunclassified